| ISSN |
2150-5330 (online) |
| Open Access |
his article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Dushyant Singh Dahiya, Abhilash Perisetti, Asim Kichloo, Amandeep Singh, Hemant Goyal, Laura Rotundo, Madhu Vennikandam, Hafeez Shaka, Gurdeep Singh, Jagmeet Singh, Sailaja Pisipati, Mohammad Al-Haddad, Madhusudhan R Sanaka and Sumant Inamdar |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dushyant Singh Dahiya, MD, Doctor, Department of Internal Medicine, Central Michigan University College of Medicine, 1015 S Washington Ave, Saginaw, MI 48601, United States. dush.dahiya@gmail.com |
| Key Words |
Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Readmissions; Trends |
| Core Tip |
This retrospective interrupted trend study analyzed 30 d readmissions of Crohn’s disease (CD) and ulcerative colitis (UC) in the United States from 2010–2018. There was a rising trend for 30 d all-cause readmission rate of CD and UC, and CD- and UC-specific readmission rate throughout the study period. However, we noted no change in the risk adjusted trends of inpatient mortality and mean length of hospital stay (LOS) for 30 d readmissions of CD and UC. Furthermore, there was no statistical difference in the trends for 30 d all-cause readmission rate, inpatient mortality, and mean LOS between CD and UC readmissions. |
| Publish Date |
2022-05-18 11:24 |
| Citation |
Dahiya DS, Perisetti A, Kichloo A, Singh A, Goyal H, Rotundo L, Vennikandam M, Shaka H, Singh G, Singh J, Pisipati S, Al-Haddad M, Sanaka MR, Inamdar S. Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma. World J Gastrointest Pathophysiol 2022;13(3): 85-95 |
| URL |
https://www.wjgnet.com/2150-5330/full/v13/i3/85.htm |
| DOI |
https://dx.doi.org/10.4291/wjgp.v13.i3.85 |
